A proinflammatory stem cell niche drives myelofibrosis through a targetable galectin-1 axis (Science Translational Medicine, 2024)

(untitled) - Li, R; Colombo, M; Wang, G; Rodriguez-Romera, A; Benlabiod, C; Jooss, NJ; O'Sullivan, J; Brierley, CK; Clark, S-A; Pérez Sáez, JM; Fernández, PA; Schoof, EM; et al.